In the pandemic of COVID-19, the development of nanotechnology by professor Liao Jiunn-der from National Cheng Kung University help screen infected patient’s respiratory system within minutes of time. The developing of nanocavity technology began in 2009 and under the hard works of professor Liao, and it is stated by Liao’s team that the innovation will work with the university’s hospital and College of Medicine to conduct tests over the new Coronavirus (SARS-CoV-2).

This article was extracted from: Focus Taiwan

Previous

Industry News: Virus to Dampen Outlook For Local Technology Firms

Next

Taiwan and Japan will soon open both Border Entries for Business Professionals